Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Stoke Therapeutics
STOK
$1.85B
| $3.01M | ﹤0.01% |
223,038
+17,796
| +9% | +$108K |
|
2477
Stellantis
STLA
$21.4B
| $2.99M | ﹤0.01% |
105,654
+21,802
| +26% | +$543K |
|
2478
Vaalco Energy
EGY
$564M
| $2.98M | ﹤0.01% |
426,922
+136,853
| +47% | +$641K |
|
2479
NB Bancorp
NBBK
$1.02B
| $2.95M | ﹤0.01% |
+216,293
| New | +$3.02M |
|
2480
Domo
DOMO
$184M
| $2.95M | ﹤0.01% |
330,676
+12,992
| +4% | +$135K |
|
2481
Distribution Solutions Group
DSGR
$1.6B
| $2.95M | ﹤0.01% |
83,078
+750
| +0.9% | +$24.1K |
|
2482
Tejon Ranch
TRC
$453M
| $2.91M | ﹤0.01% |
189,071
+2,029
| +1% | +$32.8K |
|
|
AD
2483
Array Digital Infrastructure
AD
$3.03B
| $2.9M | ﹤0.01% |
79,527
+2,115
| +3% | +$82.6K |
|
2484
SkinHealth Systems
SKIN
$95.9M
| $2.88M | ﹤0.01% |
647,701
+47,005
| +8% | +$153K |
|
2485
State Street Utilities Select Sector SPDR ETF
XLU
$22.6B
| $2.87M | ﹤0.01% |
87,432
-2,538
| -3% | -$79.2K |
|
|
OLP
2486
One Liberty Properties
OLP
$530M
| $2.87M | ﹤0.01% |
126,866
+1,139
| +0.9% | +$24.2K |
|
2487
Lyell Immunopharma
LYEL
$321M
| $2.85M | ﹤0.01% |
63,971
+628
| +1% | +$26.9K |
|
|
CTLP
2488
DELISTED
Cantaloupe
CTLP
| $2.85M | ﹤0.01% |
443,636
+8,120
| +2% | +$53.6K |
|
2489
Ocular Therapeutix
OCUL
$1.86B
| $2.85M | ﹤0.01% |
313,036
+91,834
| +42% | +$652K |
|
2490
SIGA Technologies
SIGA
$232M
| $2.84M | ﹤0.01% |
331,499
+20,650
| +7% | +$118K |
|
|
FFIC
2491
DELISTED
Flushing Financial
FFIC
| $2.83M | ﹤0.01% |
224,064
+2,216
| +1% | +$31.2K |
|
2492
Enanta Pharmaceuticals
ENTA
$388M
| $2.81M | ﹤0.01% |
161,000
+13,669
| +9% | +$181K |
|
2493
Phathom Pharmaceuticals
PHAT
$684M
| $2.81M | ﹤0.01% |
264,494
+1,970
| +0.8% | +$16.7K |
|
|
ITOS
2494
DELISTED
iTeos Therapeutics
ITOS
| $2.81M | ﹤0.01% |
205,865
+4,315
| +2% | +$47K |
|
2495
Playtika
PLTK
$1.55B
| $2.8M | ﹤0.01% |
397,716
+3,394
| +0.9% | +$25K |
|
2496
Ecopetrol
EC
$34.1B
| $2.8M | ﹤0.01% |
236,783
-33,232
| -12% | -$385K |
|
2497
Axogen
AXGN
$2.42B
| $2.8M | ﹤0.01% |
346,953
+15,640
| +5% | +$140K |
|
2498
Enliven Therapeutics
ELVN
$4.15B
| $2.8M | ﹤0.01% |
159,035
+595
| +0.4% | +$9.13K |
|
2499
Pulmonx
LUNG
$85.7M
| $2.79M | ﹤0.01% |
301,372
+12,015
| +4% | +$141K |
|
2500
HCI Group
HCI
$2.28B
| $2.79M | ﹤0.01% |
24,053
+2,322
| +11% | +$228K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.